1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (7820)
  2. Meeting Abstract (3612)
  3. Review (610)
  4. Editorial (251)
  5. Book Section (189)
  6. Conference Paper (160)
  7. Research Letter (133)
  8. Correspondence (63)
  9. Miscellaneous (62)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)

More Groups

People
  1. Britta Weigelt (366)
  2. Jorge Reis-Filho (327)
  3. Mithat Gonen (309)
  4. Marc Ladanyi (304)
  5. Joseph Deasy (278)
  6. Michael Berger (278)

More People

Years
  1. 2025 (394)
  2. 2024 (1038)
  3. 2023 (1151)
  4. 2022 (1364)
  5. 2021 (1176)
  6. 2020 (1240)

More Years

Publications
  1. Blood (641)
  2. Cancer Research (542)
  3. Journal of Clinical Oncology (416)
  4. Journal of Nuclear Medicine (261)
  5. Annals of Surgical Oncology (257)
  6. Clinical Cancer Research (235)

More Publications

Publishers
  1. Nature Publishing Group (1308)
  2. Elsevier Inc. (1173)
  3. American Association for Cancer Research (1039)
  4. Springer (818)
  5. Cell Press (719)
  6. American Society of Hematology (697)

More Publishers

Results (12936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fluorescence imaging of peripheral nerves by a Na(v)1.7-targeted inhibitor cystine knot peptide
    Journal Article

    Gonzales, J.; Demetrio de Souza Franca, P.; Jiang, Y.; Pirovano, G.; Kossatz, S.; Guru, N.; Yarilin, D.; Agwa, A. J.; Schroeder, C. I.; Patel, S. G.; more...
    Bioconjugate Chemistry (2019)

    Fulltext@MSK | Save
  • Cardio-pulmonary substructure segmentation of CT images using convolutional neural networks
    Conference Paper

    Haq, R.; Hotca, A.; Apte, A.; Rimner, A.; Deasy, J. O.; Thor, M.
    Springer (2019)

    Fulltext@MSK | Save
  • PHiSeg: Capturing uncertainty in medical image segmentation
    Conference Paper

    Baumgartner, C. F.; Tezcan, K. C.; Chaitanya, K.; Hötker, A. M.; Muehlematter, U. J.; Schawkat, K.; Becker, A. S.; Donati, O.; Konukoglu, E.
    Springer (2019)

    Fulltext@MSK | Save
  • Unsupervised subtyping of cholangiocarcinoma using a deep clustering convolutional autoencoder
    Conference Paper

    Muhammad, H.; Sigel, C. S.; Campanella, G.; Boerner, T.; Pak, L. M.; Büttner, S.; Ijzermans, J. N. M.; Koerkamp, B. G.; Doukas, M.; Jarnagin, W. R.; more...
    Springer (2019)

    Fulltext@MSK | Save
  • Integrating cross-modality hallucinated MRI with CT to aid mediastinal lung tumor segmentation
    Conference Paper

    Jue, J.; Jason, H.; Neelam, T.; Andreas, R.; Sean, B. L.; Joseph, D. O.; Harini, V.
    Springer (2019)

    Fulltext@MSK | Save
  • Elucidating mechanisms of resistance to targeted therapies in mutant EGFR or KRAS driven lung adenocarcinoma harboring dual loss of p53 and RB1
    Meeting Abstract

    Inoue, Y.; Somwar, R.; Ladanyi, M.; Lockwood, W.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A phase 2 trial of cabozantinib in ROS1-rearranged lung adenocarcinoma
    Meeting Abstract

    Guo, R.; Preeshagul, I.; Schoenfeld, A.; McCarthy, C.; Makhnin, A.; Plodkowski, A.; Ginsberg, M.; Davare, M.; Delasos, L.; Somwar, R.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A novel activating MAP2K1 in-frame deletion mediates acquired resistance to ROS1 TKIs in a patient with ROS1 fusion-positive NSCLC
    Meeting Abstract

    Sato, H.; Schoenfeld, A.; Siau, E.; Suzawa, K.; Yue, C.; Offin, M.; Drilon, A.; Davare, M.; Riely, G.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • PET imaging of [(18)F]PARP inhibitor as a pharmacodynamic biomarker of talazoparib in small cell lung cancer PDXs
    Meeting Abstract

    Lok, B.; Laird, J.; Carney, B.; Kossatz, S.; De Stanchina, E.; Reiner, T.; Poirier, J.; Rudin, C.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Tissue-based molecular and histologic landscape of acquired resistance to osimertinib in patients with EGFR-mutant lung cancers
    Meeting Abstract

    Schoenfeld, A.; Chan, J.; Rizvi, H.; Somwar, R.; Kubota, D.; Daneshbod, Y.; Chang, J.; Offin, M.; Arcila, M.; Pe'Er, D.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save